Clinical Orthopaedics and Related Research®

, Volume 469, Issue 8, pp 2092–2095 | Cite as

Biographical Sketch: Fuller Albright, MD 1900–1969

Symposium: Bone Quality: From Bench to Bedside The Classic
First Online:

Abstract

This biographical sketch on Fuller Albright corresponds to the historic text, The Classic: The Metabolic Effects of Steroid Hormones in Osteoporosis, available at DOI  10.1007/s11999-011-1832-z.

Keywords

Osteoporosis Endometrial Cancer Parathyroid Gland Endometrial Hyperplasia Pure Science 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Albright F. Metropathia hemorrhagica. J Maine Med Assoc. 1938;29:235–238.Google Scholar
  2. 2.
    Albright F. Proceedings of the thirty-sixth annual meeting of the American Society for Clinical Investigation held in Atlantic City, NJ, May 8, 1944. J Clin Invest. 1944;23:921–952.CrossRefGoogle Scholar
  3. 3.
    Albright F. Osteoporosis. Ann Intern Med. 1947;27:861–882.PubMedGoogle Scholar
  4. 4.
    Albright F. A page out of the history of hyperparathyroidism. J Clin Endocrinol Metab. 1948;8:637–657.PubMedCrossRefGoogle Scholar
  5. 5.
    Albright F. Hypoparathyroidism as a cause of osteomalacia. J Clin Endocrinol Metab. 1956;16:419–425.PubMedCrossRefGoogle Scholar
  6. 6.
    Albright F, Bauer W, Aub JC. Studies of calcium and phosphorus metabolism: VIII. The influence of the thyroid gland and the parathyroid hormone upon the total acid–base metabolism. J Clin Invest. 1931;10:187–219.PubMedCrossRefGoogle Scholar
  7. 7.
    Albright F, Bauer W, Claflin D, Cockrill Jr. Studies in parathyroid physiology: III. The effect of phosphate ingestion in clinical hyperparathyroidism. J Clin Invest. 1932;11:411–435.PubMedCrossRefGoogle Scholar
  8. 8.
    Albright F, Bauer W, Cockrill JR, Ellsworth R. Studies on the physiology of the parathyroid glands: II. The relation of the serum calcium to the serum phosphorus at different levels of parathyroid activity. J Clin Invest. 1931;9:659–677.PubMedCrossRefGoogle Scholar
  9. 9.
    Albright F, Bauer W, Ropes M, Aub JC. Studies of calcium and phosphorus metabolism: IV. The effect of the parathyroid hormone. J Clin Invest. 1929;7:139–181.PubMedCrossRefGoogle Scholar
  10. 10.
    Albright F, Bloomberg E, Drake T, Sulkowitch HW. A comparison of the effects of A.T. 10 (dihydrotachysterol) and vitamin D on calcium and phosphorus metabolism in hypoparathyroidism. J Clin Invest. 1938;17:317–329.PubMedCrossRefGoogle Scholar
  11. 11.
    Albright F, Bloomberg E, Smith P. Postmenopausal osteoporosis. Trans Assoc Am Physicians. 1940;55:298–305.Google Scholar
  12. 12.
    Albright F, Butler AM, Hampton AO, Smith P. Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction, with precocious puberty in females: report of five cases. N Engl J Med. 1937;216:727–746.CrossRefGoogle Scholar
  13. 13.
    Albright F, Ellsworth R. Studies on the physiology of the parathyroid glands: I. calcium and phosphorus studies on a case of idiopathic hypoparathyroidism. J Clin Invest. 1929;7:183–201.PubMedCrossRefGoogle Scholar
  14. 14.
    Albright F, Forbes AP, Bartter FC. The effect of testosterone propionate on the 11-oxysteroid excretion of patients with Cushing’s syndrome. Trans Conf Metab Asp Conval. 1947;60:158–163.PubMedGoogle Scholar
  15. 15.
    Albright F, Forbes AP, Henneman PH. Pseudo-pseudohypoparathyroidism. Trans Assoc Am Physicians. 1952;65:337–350.PubMedGoogle Scholar
  16. 16.
    Albright F, Sulkowitch HW, Bloomberg E. A comparison of the effects of vitamin D, dihydro-tachysterol (A.T. 10), and parathyroid extract on the disordered metabolism of Rickets. J Clin Invest. 1939;18:165–169.PubMedCrossRefGoogle Scholar
  17. 17.
    Asbell B. The Pill: A Biography of the Drug That Changed the World. New York, NY: Random House; 1995.Google Scholar
  18. 18.
    Aub JC, Albright F, Bauer W, Rossmeisl E. Studies of calcium and phosphorus metabolism: VI. In hypoparathyroidism and chronic steatorrhea with tetany with special consideration of the therapeutic effect of thyroid. J Clin Invest. 1932;11:211–234.PubMedCrossRefGoogle Scholar
  19. 19.
    Axelrod L. Bones, stones and hormones: the contributions of Fuller Albright. N Engl J Med. 1970;283:964–970.PubMedCrossRefGoogle Scholar
  20. 20.
    Banting FG, Best CH. Pancreatic extracts. 1922. J Lab Clin Med. 1990;115:254–272.PubMedGoogle Scholar
  21. 21.
    Bartter FC, Forbes AP, Albright F. A comparison of the effect on bone formation of the hyperadrenocorticism of Cushing’s syndrome with that induced by adrenocorticotropic hormone. J Clin Endocrinol Metab. 1948;8:592.PubMedGoogle Scholar
  22. 22.
    Bartter FC, Sniffen RC, Simmons FA, Albright F, Howard RP. Effects of chorionic gonadotropin (APL) in male eunuchoidism with low follicle-stimulating hormone; aqueous solution versus oil and beeswax suspension. J Clin Endocrinol Metab. 1952;12:1532–1550.PubMedCrossRefGoogle Scholar
  23. 23.
    Daayana S, Holland CM. Hormone replacement therapy and the endometrium. Menopause Int. 2009;15:134–138.PubMedCrossRefGoogle Scholar
  24. 24.
    Dickens C. Great Expectations. New York, NY: Dodd, Mead; 1942.Google Scholar
  25. 25.
    Drake TG, Albright F, Castleman B. Parathyroid hyperplasia in rabbits produced by parenteral phosphate administration. J Clin Invest. 1937;16:203–206.PubMedCrossRefGoogle Scholar
  26. 26.
    Elrick H, Albright F, Bartter FC, Forbes AP, Reeves JD. Further studies on pseudo-hypoparathyroidism: report of four new cases. Acta Endocrinol (Copenh). 1950;5:199–225.Google Scholar
  27. 27.
    Forbes AP. Fuller Albright. His concept of postmenopausal osteoporosis and what came of it. Clin Orthop Relat Res. 1991:128–141.Google Scholar
  28. 28.
    Forbes AP, Albright F. A comparison of the 17-ketosteroid excretion in Cushing’s syndrome associated with adrenal tumor and with adrenal hyperplasia. J Clin Endocrinol Metab. 1951;11:926–935.PubMedCrossRefGoogle Scholar
  29. 29.
    Forbes AP, Henneman PH, Griswold GC, Albright F. Syndrome characterized by galactorrhea, amenorrhea and low urinary FSH: comparison with acromegaly and normal lactation. J Clin Endocrinol Metab. 1954;14:265–271.PubMedCrossRefGoogle Scholar
  30. 30.
    Fuller. Fuller Albright Award. The American Society for Bone and Mineral Research. Available at: http://www.asbmr.org/meetings/asbmrawards/detail.aspx?cid=0a2b96b5-4163-49f9-917e-8b3d5ca91864. Accessed Dec. 17, 2009.
  31. 31.
    Howard JE. Fuller Albright: The endocrinologists’ clinical endocriniologist. Perspect Biol Med. 1981;24:374–381.PubMedGoogle Scholar
  32. 32.
    Ingalls TH, Donaldson G, Albright F. The locus of action of the parathyroid hormone: experimental studies with parathyroid extract on normal and nephrectomized rats.. J Clin Invest. 1943;22:603–608.PubMedCrossRefGoogle Scholar
  33. 33.
    Kupperman HS, Bernstein A, Forbes AP, Cope O, Albright F. Remission in Cushing’s syndrome after bilateral hemiadrenalectomy. J Clin Endocrinol Metab. 1953;13:154–164.PubMedCrossRefGoogle Scholar
  34. 34.
    Kyes P, Potter TS. Physiological marrow ossification in female pigeons. Anat Rec. 1934;60:377–379.CrossRefGoogle Scholar
  35. 35.
    Leaf A. Fuller Albright. Biographical Memoirs. Washington, D.C.: The National Academies Press; 1976:2–11.Google Scholar
  36. 36.
    McCune DJ, Bruch H. Osteodystrophia fibrosa: report of a case in which the condition was combined with precocious puberty, pathologic pigmentation of the skin and hyperthyroidism, with a review of the literature. Am J Dis Child. 1937;54:806–848.Google Scholar
  37. 37.
    Moldawer MP, Albright F, Benedict PH, Forbes AP, Henneman PH. Eunuchoidism with low urinary follicle-stimulating hormone in the female: comparison with this syndrome in the male and with the premenarchal menopause. J Clin Endocrinol Metab. 1958;18:1–14.PubMedCrossRefGoogle Scholar
  38. 38.
    Patlak M. Bone builders: the discoveries behind preventing and treating osteoporosis. FASEB J. 2001;15:1677E–E.PubMedCrossRefGoogle Scholar
  39. 39.
    Pfeiffer CA, Gardner WU. Skeletal changes and blood serum calcium level in pigeons receiving estrogens. Endocrinology. 1938;23:485–491.CrossRefGoogle Scholar
  40. 40.
    Reifenstein EC, Albright F. The metabolic effects of steroid hormones in osteoporosis. J Clin Invest. 1947;26:24–56.CrossRefGoogle Scholar
  41. 41.
    Reifenstein EC, Forbes AP, Albright F, Donaldson E, Carroll E. Effect of methyl testosterone on urinary 17-ketosteroids of adrenal origin. J Clin Invest. 1945;24:416–434.PubMedCrossRefGoogle Scholar

Copyright information

© The Association of Bone and Joint Surgeons® 2011

Authors and Affiliations

  1. 1.Department of OrthopaedicsThe Ohio State UniversityColumbusUSA

Personalised recommendations